IPC Subgroup
A61K 47/62 the modifying agent being a protein, peptide or polyamino acid
Introduced: January 2017
Full Title
Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient > the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates > the non-active ingredient being a modifying agent > the modifying agent being a protein, peptide or polyamino acid
Classification Context
- Section:
- HUMAN NECESSITIES
- Class:
- MEDICAL OR VETERINARY SCIENCE; HYGIENE
- Subclass:
- PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
3 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- A61K 47/64 Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K 47/65 Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
- A61K 47/66 the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
Top Applicants
Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT
- PHILIPS ELECTRONICS NL 18,523
- NOVARTIS CH 14,253
- COVIDIEN US 13,953
- ROCHE CH 12,005
- CHINESE ACADEMY OF SCIENCES 11,955
- UNIVERSITY OF CALIFORNIA US 11,692
- HARVARD UNIVERSITY US 11,596
- L'OREAL FR 11,593
- P&G (PROCTER & GAMBLE COMPANY) US 11,297
- OLYMPUS CORPORATION JP 9,594